Taste Of Capital
  • Politics
  • Investing
  • Business
  • Stock
Home Investing European defence stocks plunge as US joins Israel in Iran strikes
Investing

European defence stocks plunge as US joins Israel in Iran strikes

by admin June 23, 2025
June 23, 2025

A wave of selling hit European defence stocks on Monday, as investors reacted to the United States launching coordinated military strikes on Iranian nuclear facilities in Fordo, Isfahan, and Natanz.

The escalation followed President Donald Trump’s announcement last Friday that a decision on military action would be made “within the next two weeks.”

The swift execution of that decision over the weekend triggered volatility across global markets, with the sell-off in Europe’s defence sector contrasting sharply with gains in several US-listed defence stocks.

German, Swedish, and French defence stocks lead losses

Major European defence contractors saw sharp declines as trading opened on 23 June.

Germany’s Rheinmetall dropped 4.13% in early trade, while Sweden’s Saab fell 3.25%. France’s Thales also slipped by around 5.40%.

Other names followed the same downward trend. Shares of Hensoldt and RENK Group in Germany also recorded losses.

Italy’s Leonardo and France’s Thales remained among the day’s biggest decliners.

However, Poland’s Lubawa bucked the pattern, rising 3.5% in early trade, making it the only major regional defence stock to trade higher.

US defence stocks rise after Iran airstrikes

While European defence shares slumped, several US-based defence firms posted modest premarket gains.

Shares of RTX Corporation and Northrop Grumman were up 0.53% and 0.62% respectively, while L3Harris and General Dynamics added 0.34% and 0.90%, respectively.

Lockheed Martin saw a 0.42% increase. Boeing and General Electric, both with more diversified operations, were the only US defence majors in the red.

The US airstrikes involved the deployment of GBU-57 Massive Ordnance Penetrators, developed by Boeing.

The bombs were delivered using Northrop Grumman’s B-2 bomber aircraft, highlighting the US defence sector’s direct involvement in the offensive.

Geopolitical risks shake global markets and currencies

The US-led strikes intensified concerns of a broader conflict in the Middle East.

Iran’s parliament responded by reportedly approving the closure of the Strait of Hormuz — a key maritime chokepoint for global oil trade.

Analysts at Maybank warned that such a move could prompt Iran to exit the Nuclear Non-Proliferation Treaty and cease cooperation with the International Atomic Energy Agency.

In the currency markets, the US dollar gained strength. The dollar index rose 0.3% by 8:25 am in London.

Meanwhile, traditional safe havens such as the Swiss franc remained flat, and the Japanese yen weakened significantly, falling 0.7% against the dollar, 0.5% against the euro, and 0.7% against the pound.

Bank of America analysts noted that Japan’s dependency on Middle Eastern oil — over 90% of its imports — makes the yen particularly sensitive to regional conflict.

They added that USD/JPY may serve as a hedge against further escalation.

Broader market impact and oil concerns

Across Europe, major indices opened lower. France’s CAC 40 led losses, down 0.99%, while Germany’s DAX slipped 0.88%, and Italy’s FTSE MIB lost 1.32%.

The pan-European Stoxx 600 index was down 0.62%, with most sectors in the red apart from oil and gas, which saw some gains amid rising crude prices.

Jeep maker Stellantis saw particularly sharp movement, falling 1.47% after announcing a new management team under CEO Antonio Filosa.

In Asia-Pacific markets, sentiment was also dampened by geopolitical tensions, with oil-importing economies such as Japan, South Korea, and India facing increased pressure due to energy price volatility.

The post European defence stocks plunge as US joins Israel in Iran strikes appeared first on Invezz

previous post
Interview: More couples embracing non-monogamy together, often led by women, says Ashley Madison’s Paul Keable
next post
Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Related Posts

LATAM crypto news: innovation in Mexico, fraud in Venezuela, adoption...

June 29, 2025

Canada’s GDP slips in April as manufacturing falters

June 28, 2025

Russell 2000 to reach a new all-time high within 5...

June 28, 2025

Germany says DeepSeek illegally sends data to China, urges Apple,...

June 28, 2025

London braces for scorching heatwave, hottest start to Wimbledon expected

June 28, 2025

Snap stock: 3 reasons why it looks better than a...

June 28, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Stock News

    • Citi Wealth CIO says traders ignoring warning signs in S&P 500

      June 29, 2025
    • Top risks for top ETFs like VOO, QQQ, and DIA in the second half of 2025

      June 29, 2025
    • Cloudflare stock price forecast: eying ATH after flipping key resistance

      June 29, 2025
    • What next for the Dave stock price after the 3,300% surge?

      June 29, 2025
    • Here’s why the Celsius Holdings stock price is ripe for more gains

      June 29, 2025
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TasteOfCapital.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
    Copyright © 2025 TasteOfCapital.com All Rights Reserved.

    Taste Of Capital
    • Politics
    • Investing
    • Business
    • Stock